COVID 19 Serology in Pulmonologists
NCT04422574 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2020-06-09
Summary
Respiratory physicians are highly exposed workers to Covid-19 as they perform spirometry, endoscopy, and manage Covid-19 in first line for most of them. Moreover, none reported to have apply increased levels of protection for performing these acts in the most active period of viral circulation, until the lockdown. Whether they were most frequently immunized against SARS-CoV-2 at the end of the first wave than the general population is of utmost importance individually but also worldwide
Conditions
- Covid 19
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Arnaud Bourdin, MD PhD · University Hospital, Montpellier
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2020-05-01
- Completion
- 2020-05-30
Countries
- France
Study Locations
More Related Trials
-
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196 ·Status: RECRUITING
-
Blood Fibrocytes During an Exacerbation and Lung Function Decline in Patients With COPD in Primary Care.
NCT04005833 ·Status: TERMINATED
-
Biological Determinants of Sputum Rheology in Chronic Airway Diseases
NCT04081740 ·Status: COMPLETED
-
Analysis of the Dynamics of the Lung Microbiota During Acute Exacerbation of COPD Requiring Admission to Intensive Care Unit
NCT03641235 ·Status: UNKNOWN
-
Impact of COVID19 on Asthma Patients in Spain
NCT05064501 ·Status: WITHDRAWN
-
Mechanisms of Lung Defense and Their Relationship With Airway Infection in Chronic Obstructive Pulmonary Disease (COPD)
NCT01976130 ·Status: UNKNOWN ·Phase: NA
-
Covid-19 Respiratory Sequelae French Cohort
NCT05075785 ·Status: COMPLETED
-
Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease
NCT02551614 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD
NCT05437198 ·Status: RECRUITING
-
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
NCT04987528 ·Status: ACTIVE_NOT_RECRUITING
-
Phenotypic Characterization of Alveolar Macrophages 2016 (Caract-Aires-2016)
NCT03250897 ·Status: UNKNOWN
-
Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection
NCT04584671 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development
NCT05783544 ·Status: RECRUITING ·Phase: NA
-
The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation
NCT04865861 ·Status: UNKNOWN
-
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae
NCT04519320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests
NCT05835128 ·Status: UNKNOWN
-
Bronchial Infection in Patients With COPD and Frequent Exacerbations.
NCT03259022 ·Status: UNKNOWN
-
Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD
NCT00281203 ·Status: COMPLETED
-
The Relationship Between Covid-19 and Pneumothorax in Patients Hospitalized With Covid-19 During the Pandemic
NCT05677776 ·Status: COMPLETED
-
Persistent Dyspnea in Post COVID_19 and Pulmonary Function
NCT05228678 ·Status: UNKNOWN
-
Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis
NCT01247142 ·Status: COMPLETED
-
Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap
NCT04056364 ·Status: UNKNOWN
-
Respiratory Microbiome in COPD and Associated Inmune Response.
NCT03321708 ·Status: UNKNOWN
-
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
NCT02779478 ·Status: RECRUITING
-
Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease
NCT05214508 ·Status: COMPLETED ·Phase: NA